A number of studies have identified hormonal changes in women during their
reproductive lifespan, many focusing upon changes in women over the age of
40 years. The present study has determined the effect of increasing age on
hormone levels over three decades.
Daily early morning urine samples were assayed for estrone-3-glucuronide (E
3 G), pregnanediol-3-glucuronide (P3 G), testosterone-17-glucuronide (T17 G
), FSH and LH. An examination of the validity of using creatinine as a volu
me adjuster in urine samples formed an integral part of the analysis. Volun
teers were healthy women who had regular (25-35 days) cycles, were not taki
ng oral contraceptives, hormone therapies or any other medication. Three ag
e groups were compared: 20-29 years (n = 13), 30-39 years (n = 9) and 40-49
years (n = 13). Statistical analyses were carried out using two-way ANOVA
and post hoc t-tests.
Creatinine excretion, despite revealing no cycle-related variation in any a
ge group, showed a decline with increasing age. Creatinine output was signi
ficantly lower in the 40-49 years age soup in all phases of the cycle than
in the 20-29 and 30-39 groups (P < 0.0001). Uncorrected levels of E3 G were
significantly higher in the 30-39 years group when compared with the 40-49
age group (P < 0.0001). Uncorrected P3 G output was significantly higher i
n women aged 20-29 years than in women aged 40-49 years (P < 0.001) and lev
els of uncorrected T17 G were higher in the 20-29 year age group when compa
red with the 30-39 or 40-49 years age group (P < 0.0001).
The present study is consistent with previous reports that have revealed a
decline in creatinine clearance with increasing age, and therefore casts in
to some doubt the validity of using creatinine clearance as a procedure to
correct for volume fluctuations in differing age groups of women. The study
also demonstrates unequivocally that age-related variations in hormone lev
els are not restricted to women over 40 years of age. The novel finding of
highly significant differences in mean levels of T17 G between the age grou
ps is of considerable interest. It is presently unclear whether this result
ed from specifically increased ovarian and/or adrenal secretion. The possib
le impacts of changes in testosterone levels during the female reproductive
lifespan merits further study.